Mode
Text Size
Log in / Sign up
Phase 3 Completed N=405 Randomized Double-blind Treatment

Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy

Source: ClinicalTrials.gov NCT00654069 ↗
Enrolled (actual)
405
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: SPID48 — 604.48; 998.46; 1224.97 score on a scale
◆ Published Evidence
Established
23citations · ~2 / year
Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery.
Current medical research and opinion · 2011 · Likely link

Summary

The purpose of this study is to determine whether oxycodone HCl and niacin are effective in the treatment of pain following bunionectomy surgery.

Linked Publications

  • Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery.
    Current medical research and opinion · 2011 · 23 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
SPID48
604.48; 998.46; 1224.97

Eligibility Criteria

Inclusion Criteria

  • Patient is male or female at least 18 years of age
  • For women of child-bearing potential: woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control
  • Patient is scheduled to have a bunionectomy
  • Patient must be willing to stay at the study site for at least 48 hours from the initial dose of study medication post-surgery

Exclusion Criteria

  • Patient has a current disease or history of a disease that will impact the study or the patient's well-being
  • Patient has used or intends to use any of the medications that are prohibited by the protocol
  • Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen
  • Patient is hypersensitive to any of the medications to be used in the study
  • Patient has taken another investigational drug within 30 days prior to Screening
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00654069) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search